Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Rubicon Organics Acquires Hope Facility to Accelerate Premium Cannabis Growth Strategy
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- June 5, 2025 – Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics”, “Rubicon” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the closing of its acquisition of an operational, purpose-built 47,500 sq. ft. indoor cultivation facility in Hope, British Columbia. The acquisition is a key milestone in Rubicon's growth strategy to expand premium and certified organic cannabis production.» Mehr auf globenewswire.com
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm"), a pharmaceutical company specialized in precision-based cannabinoids, announced the closing of the sale of its Hope, British Columbia facility (the “Hope Facility”) to Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) for $4.5 million in cash (the “Transaction”). In parallel, the Company is expanding annual international cultivation capacity at its EU GMP-certified facility in Napanee, Ontario (the “Napanee Facility”) by approximately 30% in 2025.» Mehr auf globenewswire.com
Rubicon Organics Inc. (ROMJF) Q1 2025 Earnings Call Transcript
Rubicon Organics Inc. (OTCQX:ROMJF) Q1 2025 Earnings Conference Call May 28, 2025 10:00 AM ET Company Participants Margaret Brodie - CEO Glenn Ibbott - Interim CFO Conference Call Participants Neal Gilmer - Haywood Securities Pablo Zuanic - Zuanic & Associates Josh Felker - CB1 Capital Operator Good morning, ladies and gentlemen, and welcome to the Rubicon Organics First Quarter Earnings Conference Call. At this time, all lines are in a listen-only mode.» Mehr auf seekingalpha.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | Dez. 2024 | |
---|---|---|
Umsatz | 9,51 Mio | 39,39% |
Bruttoeinkommen | 3,44 Mio | 867,49% |
Nettoeinkommen | −31,74k | 109,13% |
EBITDA | 737,45k | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 17,80 Mio€ |
Anzahl Aktien | 66,98 Mio |
52 Wochen-Hoch/Tief | 0,36€ - 0,18€ |
Dividenden | Nein |
Beta | -0,11 |
KGV (PE Ratio) | −9,58 |
KGWV (PEG Ratio) | 0,34 |
KBV (PB Ratio) | 0,66 |
KUV (PS Ratio) | 0,58 |
Unternehmensprofil
Rubicon Organics Inc. produziert und verkauft Bio-Cannabis für den Freizeit- und Medizinmarkt in Kanada. Das Unternehmen verarbeitet und verkauft Bio-Cannabis unter seinen eigenen und anderen lizenzierten Marken. Rubicon Organics Inc. wurde im Jahr 2015 gegründet und hat seinen Hauptsitz in Vancouver, Kanada.
Name | RUBICON ORGANICS INC |
CEO | Margaret Ruth Brodie CPA |
Sitz | Vancouver, bc Kanada |
Website | |
Börsengang | |
Mitarbeiter | 208 |
Ticker Symbole
Börse | Symbol |
---|---|
Tsxv | ROMJ.V |
Pnk | ROMJF |
Frankfurt | R07.F |
Düsseldorf | R07.DU |
Assets entdecken
Shareholder von RUBICON ORGANICS INC investieren auch in folgende Assets